Approaches to the Development and Use of PRO Measures: A New Roadmap

Paul Kamudoni; Nutjaree Johns; Mir-Saeed Shayegan Salek

doi:10.1007/978-981-10-8414-0_2

Approaches to the Development and Use of PRO Measures: A New Roadmap

Paul Kamudoni, Nutjaree Johns, Mir-Saeed Shayegan Salek

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Various recent developments are driving an evolution in the way PRO measures are developed. For example, drug regulatory agencies (e.g. the FDA) can now be more substantively involved or consulted on measure development work; the patients’ role is now seen as going beyond being a study subject to being involved as research partners. Use of modern test theory in development of scoring algorithms and overall measure development work is now the new ‘gold standard’.

Original language	English
Title of host publication	Living with Chronic Disease: Measuring Important Patient-Reported Outcomes
Place of Publication	Singapore
Publisher	Adis
Chapter	2
Pages	15-49
Number of pages	34
ISBN (Electronic)	978-981-10-8414-0
ISBN (Print)	978-981-10-8413-3
DOIs	https://doi.org/10.1007/978-981-10-8414-0_2
Publication status	Published - 7 Sept 2018

Access to Document

10.1007/978-981-10-8414-0_2Licence: Unspecified

Cite this

@inbook{de135b790d6d458e8d6f747d89b7c55a,

title = "Approaches to the Development and Use of PRO Measures: A New Roadmap",

abstract = "Various recent developments are driving an evolution in the way PRO measures are developed. For example, drug regulatory agencies (e.g. the FDA) can now be more substantively involved or consulted on measure development work; the patients{\textquoteright} role is now seen as going beyond being a study subject to being involved as research partners. Use of modern test theory in development of scoring algorithms and overall measure development work is now the new {\textquoteleft}gold standard{\textquoteright}.",

author = "Paul Kamudoni and Nutjaree Johns and Salek, {Mir-Saeed Shayegan}",

year = "2018",

month = sep,

day = "7",

doi = "10.1007/978-981-10-8414-0_2",

language = "English",

isbn = "978-981-10-8413-3",

pages = "15--49",

booktitle = "Living with Chronic Disease: Measuring Important Patient-Reported Outcomes",

publisher = "Adis",

}

TY - CHAP

T1 - Approaches to the Development and Use of PRO Measures: A New Roadmap

AU - Kamudoni, Paul

AU - Johns, Nutjaree

AU - Salek, Mir-Saeed Shayegan

PY - 2018/9/7

Y1 - 2018/9/7

N2 - Various recent developments are driving an evolution in the way PRO measures are developed. For example, drug regulatory agencies (e.g. the FDA) can now be more substantively involved or consulted on measure development work; the patients’ role is now seen as going beyond being a study subject to being involved as research partners. Use of modern test theory in development of scoring algorithms and overall measure development work is now the new ‘gold standard’.

AB - Various recent developments are driving an evolution in the way PRO measures are developed. For example, drug regulatory agencies (e.g. the FDA) can now be more substantively involved or consulted on measure development work; the patients’ role is now seen as going beyond being a study subject to being involved as research partners. Use of modern test theory in development of scoring algorithms and overall measure development work is now the new ‘gold standard’.

U2 - 10.1007/978-981-10-8414-0_2

DO - 10.1007/978-981-10-8414-0_2

M3 - Chapter

SN - 978-981-10-8413-3

SP - 15

EP - 49

BT - Living with Chronic Disease: Measuring Important Patient-Reported Outcomes

PB - Adis

CY - Singapore

ER -

Approaches to the Development and Use of PRO Measures: A New Roadmap

Abstract

Access to Document

Fingerprint

Cite this